HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enhanced antileukemic activity of the novel complex 2,5-dihydroxybenzoate molybdenum(VI) against 2,5-dihydroxybenzoate, polyoxometalate of Mo(VI), and tetraphenylphosphonium in the human HL-60 and K562 leukemic cell lines.

Abstract
We synthesized and studied the antitumor properties of the novel complex compound 2,5-dihydroxybenzoate molybdenum(VI) with tetraphenylphosphonium as counterion, which also acts as cancer cell growth inhibitor. A novel complex compound, the 2,5-dihydroxybenzoate molybdenum(VI) complex, (PPh4)2[Mo3O6(mu-O)2(2,5-DHBA)2] was synthesized. 1H NMR, 13C NMR, IR, and UV-Vis analyses were used for its molecular characterization. The human leukemia cell lines HL-60 and K562 were tested for their viability by assessing the metabolic activity of cells (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; MTT), the structural integrity of the cell membrane (Trypan blue assay), and cell proliferation ability (growth curves). We showed that both leukemia cell lines are induced to decreased proliferation efficiency after treatment with the novel complex, compared to 2,5-dihydroxybenzoate, tetraphenyl-phosphonium polyoxomolybdate, or tetraphenylphosphonium chloride as individual entities, in a time- and concentration-dependent manner. Our results suggest that the new 2,5-dihydroxybenzoate molybdenum(VI) complex may provide a valuable tool in cancer chemotherapy.
AuthorsHellinida Thomadaki, Alexandra Karaliota, Charalambos Litos, Andreas Scorilas
JournalJournal of medicinal chemistry (J Med Chem) Vol. 50 Issue 6 Pg. 1316-21 (Mar 22 2007) ISSN: 0022-2623 [Print] United States
PMID17328533 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Gentisates
  • Onium Compounds
  • Organometallic Compounds
  • Organophosphorus Compounds
  • tetraphenylphosphonium hexaoxodi(mu-oxo)bis(2,5-dihydroxybenzoato)trimolybdenum(VI)
  • tetraphenylphosphonium polyoxomolybdate
  • tetraphenylphosphonium
  • 2,5-dihydroxybenzoic acid
Topics
  • Antineoplastic Agents (chemical synthesis, chemistry, pharmacology)
  • Cell Proliferation (drug effects)
  • Cell Survival (drug effects)
  • Drug Screening Assays, Antitumor
  • Gentisates (chemistry, pharmacology)
  • HL-60 Cells
  • Humans
  • K562 Cells
  • Leukemia, Myeloid
  • Magnetic Resonance Spectroscopy
  • Necrosis
  • Onium Compounds (pharmacology)
  • Organometallic Compounds (chemical synthesis, chemistry, pharmacology)
  • Organophosphorus Compounds (pharmacology)
  • Spectrophotometry, Infrared
  • Spectrophotometry, Ultraviolet

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: